Have a personal or library account? Click to login
Biopharmaceutical aspects of the development of transdermal forms of Lisinopril dihydrate Cover

Biopharmaceutical aspects of the development of transdermal forms of Lisinopril dihydrate

Current Issues in Pharmacy and Medical Sciences
Volume 37 (2024): Issue 3 (September 2024)
By: Tatyana Shyteyeva,  Elena Bezchasnyuk,  Oleg Kryskiv and  Inna Baranova  
Open Access
|Sep 2024

Authors

Tatyana Shyteyeva

State Scientific Research Laboratory for Quality Control of Medicines, National University of Pharmacy, Kharkiv, Ukraine

Elena Bezchasnyuk

State Scientific Research Laboratory for Quality Control of Medicines, National University of Pharmacy, Kharkiv, Ukraine

Oleg Kryskiv

genchem@nuph.edu.ua

General Chemistry Department, National University of Pharmacy, Kharkiv, Ukraine

Inna Baranova

Organization and Economics of Pharmacy Department, National University of Pharmacy, Kharkiv, Ukraine
DOI: https://doi.org/10.2478/cipms-2024-0027 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 166 - 170
Submitted on: Dec 23, 2023
|
Accepted on: May 6, 2024
|
Published on: Sep 7, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
transdermal therapeutic system,
arterial hypertension,
ACE inhibitors,
Lisinopril dihydrate,
permeability
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2024 Tatyana Shyteyeva, Elena Bezchasnyuk, Oleg Kryskiv, Inna Baranova, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 37 (2024): Issue 3 (September 2024)Next article